Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis
Authors:
- Karmel WebbKWKarmel Webb
- Nur Masirah M. ZainNZNur Masirah M. Zain
- Iain StewartISIain Stewart
- Edward F. NashENEdward F. Nash
- Joanna L. WhitehouseJWJoanna L. Whitehouse
- Alan R. SmythASAlan R. Smyth
- Andrew K. LilleyALAndrew K. Lilley
- Alan KnoxAKAlan Knox
- Paul WilliamsPWPaul Williams
- Miguel CámaraMCMiguel Cámara
Open Access
- 3 February 2022
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 71 (2) , 001481
Abstract
Although anaerobic bacteria exist in abundance in cystic fibrosis (CF) airways, their role in disease progression is poorly understood. We hypothesized that the presence and relative abundance of the most prevalent, live, anaerobic bacteria in sputum of adults with CF were associated with adverse clinical outcomes. This is the first study to prospectively investigate viable anaerobic bacteria present in the sputum microbiota and their relationship with long-term outcomes in adults with CF. We performed 16S rRNA analysis using a viability quantitative PCR technique on sputum samples obtained from a prospective cohort of 70 adults with CF and collected clinical data over an 8 year follow-up period. We examined the associations of the ten most abundant obligate anaerobic bacteria present in the sputum with annual rate of FEV1 change. The presence of Porphyromonas pasteri and Prevotella nanceiensis were associated with a greater annual rate of FEV1 change; −52.3 ml yr−1 (95 % CI-87.7;−16.9), –67.9 ml yr−1 (95 % CI-115.6;−20.1), respectively. Similarly, the relative abundance of these live organisms were associated with a greater annual rate of FEV1 decline of −3.7 ml yr−1 (95 % CI: −6.1 to −1.3, P=0.003) and −5.3 ml yr−1 (95 % CI: −8.7 to −1.9, P=0.002) for each log2 increment of abundance, respectively. The presence and relative abundance of certain anaerobes in the sputum of adults with CF are associated with a greater rate of long-term lung function decline. The pathogenicity of anaerobic bacteria in the CF airways should be confirmed with further longitudinal prospective studies with a larger cohort of participants.Keywords
Funding Information
- National Institute for Health Research (Nottingham Biomedical Research Centre)
- Medical Research Council (G0801558/1)
- The National Biofilms Innovation Centre (BB/R012415/1)
- The National Biofilms Innovation Centre (BB/R012415/1)
This publication has 28 references indexed in Scilit:
- Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary ExacerbationsPLOS ONE, 2013
- The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of ExacerbationsPLOS ONE, 2012
- Decade-long bacterial community dynamics in cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2012
- The airway microbiome in cystic fibrosis and implications for treatmentCurrent Opinion in Pediatrics, 2011
- Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals?Thorax, 2011
- The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samplesClinical Microbiology and Infection, 2010
- Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial InfectionsPLOS Pathogens, 2008
- Use of Propidium Monoazide for Live/Dead Distinction in Microbial EcologyApplied and Environmental Microbiology, 2007
- Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2006
- Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsJournal of Cystic Fibrosis, 2003